Dawn Carter Bir, Chief Commercial Officer at REATA PHARMACEUTICALS INC (RETA), sold 60,000 shares at $150.01 ($9.8M) on 2020-11-09, disclosed to the SEC on 2020-11-10.
Open-market sale of $9.8M RETA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.01 | 30,000 | $4.5M | 46.2% |
| 2 | $175.00 | 30,000 | $5.3M | 53.8% |
| Total | $162.50 avg | 60,000 | $9.8M | 100% |
| Filing → |
| RETA | SELL | 2023-05-17 | $186K | — | Filing → |
| RETA | SELL | 2023-03-15 | $1.6M | — | Filing → |
| RETA | SELL | 2023-03-08 | $17.0M | — | Filing → |